Number of Patients With Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Viral Load <50 Copies/mL Week 48 [clinicaltrials_resource:000344ada83e0edda440d131e9c340c1]
The primary objective of this study was to evaluate the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in treatment-naïve HIV-1 infected adults.
Blood samples for HIV-1 RNA viral load measurement were collected at the Week 48 clinic visit. The number of participants with HIV-1 RNA results <50 copies/mL is reported.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Patients With Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Viral Load <50 Copies/mL Week 48 [clinicaltrials_resource:000344ada83e0edda440d131e9c340c1]
The primary objective of this study was to evaluate the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in treatment-naïve HIV-1 infected adults.
Blood samples for HIV-1 RNA viral load measurement were collected at the Week 48 clinic visit. The number of participants with HIV-1 RNA results <50 copies/mL is reported.
Bio2RDF identifier
000344ada83e0edda440d131e9c340c1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:000344ada83e0edda440d131e9c340c1
measure [clinicaltrials_vocabulary:measure]
Number of Patients With Human ...... (RNA) Viral Load <50 Copies/mL
time frame [clinicaltrials_vocabulary:time-frame]
description
The primary objective of this ...... lts <50 copies/mL is reported.
identifier
clinicaltrials_resource:000344ada83e0edda440d131e9c340c1
title
Number of Patients With Human ...... ral Load <50 Copies/mL Week 48
@en
type
label
Number of Patients With Human ...... 344ada83e0edda440d131e9c340c1]
@en